Multus
Multus is a global leader in cell culture media design for cell-based biomanufacturing, combining AI, robotic automation, and cell biology.
About Multus
Multus Biotechnology is a global leader in cell culture media design, helping biomanufacturing companies shorten their time to market while improving supply chain security. By combining high-throughput robotic automation and ML, Multus revolutionizes cell culture media development - delivering breakthrough performance and efficiency that were previously unattainable. Multus’ experienced, multi-disciplinary team of scientists and engineers is redefining the future of biomanufacturing. Harnessing the power of biology, automation, and machine learning, we accelerate the creation of high-performance, resource-efficient cell culture media, empowering the global bioeconomy and enabling the next generation of essential therapies, food, and materials.
Company Facts
- Headquarters
- London
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $14,569,914
- Last Funding Type
- series_a
- Last Funding Date
- 2023-01-16
- Website
- multus.bio
Industries & Categories
Alternative Protein, Artificial Intelligence (AI), Biopharma, Life Science, Machine Learning, Robotics, Therapeutics
Social Links
Canonical: https://fsome.com/organization/multus-1639 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.